Society guideline links: Chronic diarrhea

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Irritable bowel syndrome" and "Society guideline links: Small intestinal bacterial overgrowth" and "Society guideline links: Clostridioides difficile infection".)

International

●World Gastroenterology Organisation (WGO): Global guidelines on irritable bowel syndrome – A global perspective (2015)

●World Health Organization (WHO): Recommendations on the management of diarrhoea and pneumonia in HIV-infected infants and children (2010)

Canada

●Canadian Association of Gastroenterology (CAG): Clinical practice guideline on the management of bile acid diarrhea (2020)

●Choosing Wisely Canada: Don't routinely collect or process specimens for Clostridium difficile testing in infants less than one year of age with diarrhea (2020)

●CAG: Clinical practice guideline for the management of irritable bowel syndrome (IBS) (2019)

United States

●American Gastroenterological Association (AGA): Clinical practice guidelines on the laboratory evaluation of functional diarrhea and diarrhea-predominant irritable bowel syndrome in adults (IBS-D) (2019)

●AGA: Technical review on the evaluation of functional diarrhea and diarrhea-predominant irritable bowel syndrome in adults (IBS-D) (2019)

●Choosing Wisely: Do not routinely test for community gastrointestinal stool pathogens in hospitalized patients who develop diarrhea after day 3 of hospitalization (2019)

●American College of Gastroenterology (ACG): Monograph on management of irritable bowel syndrome (2018)

●Infectious Diseases Society of America (IDSA): Clinical practice guidelines for the diagnosis and management of infectious diarrhea (2017)

●AGA: Guideline on the pharmacological management of irritable bowel syndrome (2014)

●AGA: Technical review on the pharmacological management of irritable bowel syndrome (2014)

Europe

●British Society of Gastroenterology (BSG): Guidelines on the management of irritable bowel syndrome (2021)

●European Society for Medical Oncology (ESMO): Clinical practice guidelines on diarrhoea in adult cancer patients (2018)

United Kingdom

●British Society of Gastroenterology (BSG): Guidelines for the investigation of chronic diarrhoea in adults, 3rd edition (2018)

●National Institute for Health and Care Excellence (NICE): Clinical guideline on irritable bowel syndrome in adults – Diagnosis and management (2008, updated 2017)

●British Dietetic Association (BDA): Clinical guidelines – Systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults, update (2016)

●BDA: Clinical guidelines – Systematic review and evidence-based practice guidelines for the use of probiotics in the management of irritable bowel syndrome in adults, update (2016)

●NICE: Quality standard on irritable bowel syndrome in adults (2016)

Australia-New Zealand

●Choosing Wisely Australia: Do not investigate or treat for faecal pathogens in the absence of diarrhoea or other gastro-intestinal symptoms

Japan

●[In English] Japanese Society of Gastroenterology (JSGE): Evidence-based clinical practice guidelines for irritable bowel syndrome (2015)

●[In Japanese] JSGE: Evidence-based clinical practice guidelines for irritable bowel syndrome (2014)